PROMPT PHENYTOIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Prompt Phenytoin Sodium patents expire, and when can generic versions of Prompt Phenytoin Sodium launch?
Prompt Phenytoin Sodium is a drug marketed by Ani Pharms and Watson Labs and is included in two NDAs.
The generic ingredient in PROMPT PHENYTOIN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prompt Phenytoin Sodium
A generic version of PROMPT PHENYTOIN SODIUM was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.
Summary for PROMPT PHENYTOIN SODIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Patent Applications: | 503 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROMPT PHENYTOIN SODIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROMPT PHENYTOIN SODIUM
US Patents and Regulatory Information for PROMPT PHENYTOIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | PROMPT PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 080259-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | PROMPT PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 080905-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |